Concordia Healthcare (CXRX) PT Lowered to $0.50 at RBC Capital; '2017E Outlook Expected to Decline'
Tweet Send to a Friend
RBC Capital analyst Douglas Miehm lowered its price target on Concordia Healthcare (NASDAQ: CXRX) to $0.50 (from $1.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
